drugset / Trial / NCT03477175
Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will be conducted to assess the long-term safety of study drug(s) in participants who are enrolled in Eisai-sponsored lenvatinib studies.
Timeline
- Start
- 2018-08-16
- Primary completion
- 2023-12-21
- Completion
- 2023-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenvatinib | Small molecule | — | Oral |
| Background | Sorafenib | Small molecule | — | — |